syndrome coronavirus-2 (SARS-CoV-2), appears with a wide spectrum of mild-to-critical
clinical complications. Many clinical and experimental findings suggest the role of
inflammatory mechanisms in the immunopathology of COVID-19. Hence, cellular and
molecular mediators of the immune system can be potential targets for predicting,
monitoring, and treating the progressive complications of COVID-19. In this review, we …